These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 35956870)

  • 1. Anti-
    de Souza VMR; Maciel NB; Machado YAA; de Sousa JMS; Rodrigues RRL; Dos Santos ALS; Gonçalves da Silva MG; Martins da Silva IG; Barros-Cordeiro KB; Báo SN; Tavares JF; Rodrigues KADF
    Microorganisms; 2024 Jul; 12(7):. PubMed ID: 39065160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy.
    Mo K; Kim A; Choe S; Shin M; Yoon H
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Biological Properties of Lycopene in a Self-Emulsifying Drug Delivery System.
    Báo SN; Machado M; Da Silva AL; Melo A; Cunha S; Sousa SS; Malheiro AR; Fernandes R; Leite JRSA; Vasconcelos AG; Relvas J; Pintado M
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy.
    Chaudhuri A; Kumar DN; Shaik RA; Eid BG; Abdel-Naim AB; Md S; Ahmad A; Agrawal AK
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Evaluation of NLS-DTX Activity in Triple-Negative Breast Cancer.
    Paiva KLR; Radicchi MA; Báo SN
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
    J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
    He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
    J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Doddapaneni R; Patel K; Chowdhury N; Singh M
    Exp Cell Res; 2016 Aug; 346(1):65-73. PubMed ID: 27177833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment.
    Wang Y; Cheng W; Zhu J; He L; Ren W; Bao D; Piao JG
    Biomed Pharmacother; 2024 Jan; 170():116084. PubMed ID: 38157645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of dihydroartemisinin and docetaxel in pH-sensitive nanoparticles for treating metastatic breast cancer
    Tao J; Tan Z; Diao L; Ji Z; Zhu J; Chen W; Hu Y
    RSC Adv; 2018 Jun; 8(39):21735-21744. PubMed ID: 35541720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenesis of ZnO nanoparticles using
    Hussain A; Oves M; Alajmi MF; Hussain I; Amir S; Ahmed J; Rehman MT; El-Seedi HR; Ali I
    RSC Adv; 2019 May; 9(27):15357-15369. PubMed ID: 35514831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles.
    Chen R; Ni S; Chen W; Liu M; Feng J; Hu K
    Int J Nanomedicine; 2021; 16():5265-5279. PubMed ID: 34376979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts.
    Martin M; Ramos-Medina R; Bernat R; García-Saenz JA; Del Monte-Millan M; Alvarez E; Cebollero M; Moreno F; Gonzalez-Haba E; Bueno O; Romero P; Massarrah T; Echavarria I; Jerez Y; Herrero B; Gonzalez Del Val R; Lobato N; Rincon P; Palomero MI; Marquez-Rodas I; Lizarraga S; Asensio F; Lopez-Tarruella S
    Sci Rep; 2021 Mar; 11(1):7064. PubMed ID: 33782404
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.